4//SEC Filing
Glenn Gregory M 4
Accession 0001209191-22-061704
CIK 0001000694other
Filed
Dec 15, 7:00 PM ET
Accepted
Dec 16, 5:01 PM ET
Size
9.6 KB
Accession
0001209191-22-061704
Insider Transaction Report
Form 4
NOVAVAX INCNVAX
Glenn Gregory M
Chief Scientific Officer
Transactions
- Tax Payment
Common Stock
2022-12-14$17.23/sh−1,033$17,799→ 8,009 total - Exercise/Conversion
Common Stock
2022-12-14+3,100→ 9,042 total - Exercise/Conversion
Restricted Stock Units
2022-12-14−3,100→ 3,100 total→ Common Stock (3,100 underlying)
Footnotes (6)
- [F1]The shares were received by the Reporting Person in connection with vesting of restricted stock units ("RSUs").
- [F2]Each RSU represents a contingent right to receive one share of Novavax, Inc. (the "Company") common stock.
- [F3]Includes 278 shares acquired on January 31, 2022 and 1 share acquired on July 31, 2022, each under the Company's Amended and Restated 2013 Employee Stock Purchase Plan, as amended.
- [F4]The shares were withheld by the Company to satisfy tax withholding obligations in connection with the vesting of RSUs.
- [F5]The shares reported on this Form 4 are subject to a lock-up agreement between the Reporting Person, J.P. Morgan Securities LLC and Jefferies LLC, dated December 14, 2022.
- [F6]The RSUs subject to this grant under the Company's Amended and Restated 2015 Stock Incentive Plan, as amended, vested or will vest with respect to one-third (1/3) of the RSUs on each of the first three (3) anniversaries of the December 14, 2020 grant date, in each case subject to continued employment through such vesting date.
Documents
Issuer
NOVAVAX INC
CIK 0001000694
Entity typeother
Related Parties
1- filerCIK 0001342823
Filing Metadata
- Form type
- 4
- Filed
- Dec 15, 7:00 PM ET
- Accepted
- Dec 16, 5:01 PM ET
- Size
- 9.6 KB